Dianthus Therapeutics Company Top Insiders

Dianthus Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.1896) % which means that it has lost $0.1896 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2599) %, meaning that it created substantial loss on money invested by shareholders. Dianthus Therapeutics' management efficiency ratios could be used to measure how well Dianthus Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.23. The current Return On Capital Employed is estimated to decrease to -0.34. As of now, Dianthus Therapeutics' Non Currrent Assets Other are increasing as compared to previous years. The Dianthus Therapeutics' current Other Assets is estimated to increase to about 146.1 K, while Total Assets are projected to decrease to under 112.5 M. The current Common Stock Shares Outstanding is estimated to decrease to about 3.2 M. The current Net Loss is estimated to decrease to about (26.9 M)

Dianthus Therapeutics Workforce Comparison

Dianthus Therapeutics Insider Trading

Dianthus Therapeutics Notable Stakeholders

The success or failure of an entity such as Dianthus Therapeutics often depends on how effective the management is. Dianthus Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Dianthus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Dianthus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.